Skip to main content

Table 1 a Baseline characteristics of study participants/pregnant women (n = 344); b Baseline characteristics of study variables related to prescribed antimicrobials (n = 688)

From: Patterns of infections and antimicrobial drugs’ prescribing among pregnant women in Saudi Arabia: a cross sectional study

Variables Group Frequency (n) Percentage (%)
(a)    
 Age 15–24 77 22.4
25–34 191 55.5
35–44 73 21.3
≥ 45 3 0.9
 Drug resistance (n = 324) No 272 84.0
Yes 52 16.0
  B-lactam 20 38.5
  MDR 17 32.7
  Quinolones 15 28.8
 Mode of delivery Vaginal delivery 245 71.2
C-section 99 28.7
 Mother comorbidities No 198 56.9
Yes 146 42.4
 Maternal complications Abortions 205 29.8
Preterm pregnancies 152 22.1
 Fetal complications No 297 86.3
Yes 47 13.6
(b)
 Antimicrobial use per trimester (n = 685) First 148 21.6
Second 212 30.9
Third 325 47.4
 FDA category for safety drug use during pregnancy Category A 0 0
Category B 457 66.4
Category C 224 32.6
Category D 7 1.0
Category X 0 0
 Allergy No 633 92.0
Yes 55 8.0
  B-lactam 12 21.8
  Dopaminergic 11 20.0
  Quinolones 7 12.7
  NSAIDs 6 10.9
  Food allergy 6 10.9
  Danozol 3 5.5
  Multi drug allergy 3 5.5
  Corticosteroids 2 3.6
  Tetracycline 2 3.6
  Miscellaneous 2 3.6
  Sulfa drug 1 1.8
 Indication of antibiotic use Treatment 681 99.0
Prophylaxis 7 1.0